@article{297941f1b67449bab4964e28cc8fe75e,
title = "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial",
author = "\{DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators\} and Gerstein, \{H. C.\} and S. Yusuf and Holman, \{R. R.\} and J. Bosch and S. Anand and A. Avezum and A. Budaj and J. Chiasson and I. Conget and G. Dagenais and M. Davis and R. Diaz and N. Dinccag and M. Enjalbert and A. Escalante and G. Fodor and M. Hanefeld and T. Hedner and K. Jolly and M. Keltai and M. Laakso and F. Lanas and E. Lonn and M. McQueen and V. Mohan and A. Phillips and L. Piegas and V. Pirags and J. Probstfield and J. Shaw and I. Schmid and K. Teo and P. Zimmet and B. Zinman and J. Pogue and P. Sheridan and B. Hoogwerf and Guerrero, \{R. Ahuad\} and J. Albisu and Alvarez, \{M. S.\} and V. Arregui and H. Avaca and H. Baglivo and M. Balbuena and F. Bello and J. Bono and M. Botto and L. Brandani and M. Brandes and D. Bruera",
note = "Funding Information: The DREAM trial is funded by the Canadian Institutes of Health Research (MCT41548) as well as by Sanofi-Aventis, GlaxoSmithKline, and King Pharmaceuticals. ",
year = "2006",
month = sep,
day = "23",
doi = "10.1016/S0140-6736(06)69420-8",
language = "English",
volume = "368",
pages = "1096--1105",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier",
number = "9541",
}